Results 61 to 70 of about 581,626 (194)

Comparison Between the Acurate Neo and the Acurate Neo 2 Transcatheter Heart Valve System: Impact of Midframe Under‐Expansion

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve implantation (TAVI) with the Acurate Neo has been linked to a significant incidence of paravalvular leakage (PVL), addressed by the Acurate Neo 2 incorporating an active sealing skirt. Recent findings suggest that midframe under‐expansion is associated with worse outcomes.
Lisa Crusius, Thaddäus Ast, Stephan Haussig, Jean‐Honoré Steul, Felix J. Woitek, Peter Sick, Tomas Madej, Utz Kappert, Axel Linke, Norman Mangner   +9 more
wiley   +1 more source

Endoconduit for Transcatheter Aortic Valve Implantation

Annals of Thoracic and Cardiovascular Surgery, 2018
Access challenges are sometimes encountered in patients who require transcatheter aortic valve implantation (TAVI). Transapical (TA) access is a well-established alternative, but it is more invasive than the standard transfemoral (TF) access techniques.
Murakami, Takashi, Takahashi, Yosuke, Nishimura, Shinsuke, Iwata, Shinichi, Yamada, Tokuhiro, Yoshiyama, Minoru, Shibata, Toshihiko   +6 more
openaire   +3 more sources

The future of transcatheter aortic valve implantation [PDF]

European Heart Journal, 2015
Since the introduction of transcatheter aortic valve implantation (TAVI) into clinical practice, the treatment of aortic stenosis has changed dramatically. In the past, medical therapy with or without balloon aortic valvuloplasty was the only option for inoperable patients.
Christian W, Hamm, Mani, Arsalan, Michael J, Mack   +2 more
openaire   +2 more sources

Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Objectives To evaluate the feasibility and short‐term outcomes of transcatheter aortic valve replacement (TAVR) using balloon‐expandable Sapien valves in patients with prior endovascular aortic stent grafts. Methods We conducted a single‐center, retrospective study of 23 patients with prior endovascular aortic stent grafts who underwent TAVR ...
Iad Alhallak, Alexander Mills, Beau Bequeaith, Ken Chan, Akiko Tanaka, Anthony L. Estrera, Biswajit Kar, Richard Smalling, Abhijeet Dhoble   +8 more
wiley   +1 more source

A Mobile Thrombus Adhering to an Intra-Annular Self-Expanding Transcatheter Aortic Valve

JACC: Case Reports
An 81-year-old woman who had undergone transcatheter aortic valve implantation 3 months earlier underwent routine follow-up transthoracic echocardiography, which revealed a mobile thrombus adhering to the bioprosthetic valve.
Naoki Nishiura, MD, Yasushi Fuku, MD, Atsushi Sakata, MD, Takeshi Maruo, MD, PhD, Kazushige Kadota, MD, PhD   +4 more
doaj   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Emergency transcatheter aortic valve implantation for decompensated aortic stenosis [PDF]

, 2013
We report the case of an 84-year-old male presenting with syncope and dynamic ST-T wave changes due to decompensated severe valvular aortic stenosis undergoing successful emergency transcatheter aortic valve ...
Pilgrim, Thomas, Wenaweser, Peter, Meier, Bernhard   +2 more
core  

Conduction disturbances after transcatheter aortic valve implantation procedures – predictors and management [PDF]

, 2016
Transcatheter aortic valve implantation (TAVI) has become a safe and efficient alternative to cardiac surgery in patients with severe aortic stenosis. In many countries the number of performed TAVI procedures equals the number of surgical implantations ...
Mariusz Gąsior, Krzysztof Wilczek, Michał Długaszek, Rafał Reguła, Kamil Bujak, Piotr Chodór   +5 more
core   +1 more source

Transcatheter aortic valve implantation with SAPIEN 3 versus surgical aortic valve replacement in patients with symptomatic severe aortic stenosis at low risk of surgical mortality: a cost-utility analysis for Switzerland

Swiss Medical Weekly
AIMS OF THE STUDY: The 2021 European Society of Cardiology Guidelines on valvular heart disease recommend transcatheter aortic valve implantation (TAVI) for patients with symptomatic severe aortic stenosis at low surgical risk and age ≥75 years who are ...
Christophe Alain Wyss, Roberto Corti, Thomas Nestelberger, Pascal Candolfi, Alexis Delbaere, Barbara Fischer, Matthias Schwenkglenks, Harry Telser   +7 more
doaj   +1 more source

Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis

The Thoracic & Cardiovascular Surgeon Reports, 2021
Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs).
Maximilian Vondran, Bernd Abt, Holger Nef, Ardawan J. Rastan   +3 more
doaj   +1 more source